Perioperative Immunotherapy for Resectable Limited-Stage SCLC

Clinical trial NCT07109401 · RECRUITING

Trial details

NCT number: NCT07109401
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Perioperative Immunotherapy Limited Stage Lung Small Cell Carcinoma Resectable Small Cell Lung Cancer

Start date: 2025-03-01
Primary completion: 2028-03-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.